Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Tickers ABBV BMY NBIX NEWS
Tags Analyst Ratings General Benzinga
From Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Tickers ARGX BMY IFF IHRT
Tags IHRT ARGX IFF
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Tickers ABBV BMY LLY NEWS
Tags Market News BMY Briefs
From Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
Tickers ABBV BMY NEWS
Tags Benzinga why it's moving News
From Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
Tickers ABBV BMY NEWS
Tags Large Cap Trading Ideas News
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Tickers BMY EVO NEWS NVO
Tags Biotech Stories That Matter Benzinga
From Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags Health Care Trading Ideas News
From Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Tickers AFRM BMY BTBT BTDR
Tags Mid/Day Movers HIMS BTDR
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Tickers ABBV ALNY BMY GILD
Tags News Trading Ideas Large Cap
From Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Tickers BMY NEWS NVO TEVA
Tags Market News NVO Briefs
From Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Tickers BMY MRK NEWS SMMT
Tags Equities Market News Movers
From Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Tickers BMY
Tags Trading Ideas BZI/SHORTHIST Market News
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
Tickers BMY NEWS
Tags Market News BMY Briefs
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags CMCSA Commodities REGN
From Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
Tickers BMY
Tags BMY Recent Press Releases Market News
From Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
Tickers BMY NEWS
Tags Earnings Stories That Matter Biotech
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags NVS Briefs BMY
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags Biotech Stories That Matter Expert Ideas
From Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
Tickers BMY
Tags Market News Markets Options
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Tickers BMY IBRX MRK NEWS
Tags News Trading Ideas Health Care
From Benzinga
Why Is Evotec Stock Gaining Today?
Tickers BMY EVO NEWS
Tags Benzinga General why it's moving
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags News Trading Ideas Analyst Color
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags Market News BMY JNJ
From Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Tickers BMY CATX NEWS
Tags Biotech General Benzinga
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Market News RVPH BMY
From Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Tickers BMY
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags LLY SAVA NVCR
From Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Tickers AAPL AI BMY GILD
Tags SPY Large Cap AI
From Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Tickers BMY CRM PFE
Tags Top Stories Benzinga Jeff Smith
From Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
Tickers BMY NEWS
Tags FDA Stories That Matter Biotech
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.